Information Provided By: 
Fly News Breaks for February 27, 2020
MEDP
Feb 27, 2020 | 07:34 EDT
Credit Suisse analyst Erin Wilson Wright raised the firm's price target on Medpace to $105 from $99 on a higher view and greater conviction in its growth prospects in a strong CRO fundamental backdrop. The analyst keeps an Outperform rating on the shares.
News For MEDP From the Last 2 Days
MEDP
Apr 24, 2024 | 07:15 EDT
Guggenheim raised the firm's price target on Medpace to $464 from $453 and keeps a Buy rating on the shares after an EBITDA and EPS beat-and-raise was supported by "generally positive commentary" on the call. Demand remains strong and Medpace has found ways to be more efficient, meeting its demand needs with lower headcount growth, adds the analyst, who notes that management continues to expect the current environment to support accelerating revenue growth in 2025.
MEDP
Apr 24, 2024 | 06:42 EDT
MEDP
Apr 23, 2024 | 08:00 EDT
MEDP
Apr 23, 2024 | 07:52 EDT
MEDP
Apr 22, 2024 | 18:11 EDT
Check out this evening's top movers from around Wall Street, compiled by The Fly. HIGHER AFTER EARNINGSCrane... To see the rest of the story go to thefly.com. See Story Here
MEDP
Apr 22, 2024 | 16:26 EDT
MEDP
Apr 22, 2024 | 16:20 EDT
Reports Q1 revenue $511.0M, consensus $512.6M
